Loading...

CWD CALIBERCOS INC Capital Structure Changes 8-K Filing

CLBR

CWD

CALIBERCOS INC

(CWD)

2025 8-K

Token Investment

Compliance Regained

Q3 Financial Results

Quarterly Results Announcement

Note Conversion Program

Investor Presentation

Regained Compliance

Strategic Purchase

Financial Results Update

EV Charging Partnership

New Board Member

Joint Venture Milestone

Accounting Change

Digital Asset Strategy

Digital Asset Purchase

Funding Agreement

New Advisory Appointment

Token Purchase Announcement

Crypto Advisory Board

Digital Asset Strategy

Joint Venture Agreement

Second Quarter Results

Earnings Releases

Debt Restructuring

Compliance with Nasdaq List...

Financial Statements

Geographic Expansion

Financial Statements

Funding & Approval

Underwriting Agreement

Earnings Report

Q4 Financial Results

Securities Agreement

Financial Results

New Preferred Stock

Preferred Stock Issuance

Nasdaq Compliance

Q3 Financial Results

Investor Presentation

Earnings Announcement

Investor Presentation

Property Acquisition

New Fund Launch

Q2 Financial Results

Earnings Reports

Earnings Reports

Earnings Report

Appointment of COO

Financial Results Rescheduled

Rescheduling Earnings Report

Regulation FD Disclosure

Earnings Reports

Grand Opening Announcement

Investor Conferences

Co-development of picklebal...

Financial Targets Announcement

Earnings Report

Disposals and divestitures

Investor Conferences

Acquisition of Hotel Proper...

Appointment of Director

Earnings Report

Expansion Announcement

Earnings Releases

Launch of Core+ Growth & In...

Partnership Announcement

Public Offering and Corpora...

External Links:

On April 21, 2025, CaliberCos Inc. shareholders approved a 1-for-20 reverse stock split of both Class A and Class B common stocks, reducing outstanding shares from approx. 18.6 million to 928,715 shares, effective May 2, 2025.

AI Assistant

CALIBERCOS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.